I’m a Clinician. Discover the advantages of EasyM™ mass spectrometry-based blood test for MRD monitoring in multiple myeloma
You might get imaging tests. X-rays can show spots of bone damaged by multiple myeloma. You may also need a CT scan, MRI, or PET scan. Multiple Myeloma Complications Multiple myeloma can cause problems including: Bone problems. Your bones can become weaker, leading to fractures. Blood proble...
Myeloma is the second most common blood cancer, but it is not a common cancer. An estimated 32,110 new patients will be diagnosed with myeloma in the United States in 2019, and men are diagnosed with the condition slightly more frequently than women. The mortality statistic in the U.S. i...
blooddiagnosiscase-control studiesinflammatorymultiple myelomaprimary careBackgroundKoshiaris, ConstantinosVan den Bruel, AnnOke, Jason L.Nicholson, Brian D.Shephard, ElizabethBraddick, MickHamilton, WilliamUniv Oxford Nuffield Dept Primary Care Hlth Sci Radcliffe Primary Care Bldg Woodstock Rd Oxford...
Multiple myeloma (MM) is a plasmocytemalign a n t p roliferative disease [1,2]. It causesdysplasia of clonal plasmocyte in marrow, bringsthe secretion of monoclonal immune globulinor its fragment (M protein), inducing relatedorgans or tissues lesion. MM has a diversity ofclinical features su...
In an interview, Emma Searle, MBChB, PhD, MA, MRCP, FRCPath, discussed results from cohort E of the MajesTEC-2 study of teclistamab in relapsed/refractory multiple myeloma.
et al. Semi-ambulatory autologous peripheral blood SCT in 79 patients with multiple myeloma. Bone Marrow Transplant 48, 996–997 (2013). https://doi.org/10.1038/bmt.2012.259 Download citation Published28 January 2013 Issue DateJuly 2013 DOIhttps://doi.org/10.1038/bmt.2012.259 Springer Nature ...
Multiple myeloma (MM) is a plasma cell malignancy in which monoclonal plasma cells proliferate in bone marrow, resulting in an overabundance of monoclonal paraprotein (M protein), destruction of bone, and displacement of other hematopoietic cell lines. [1] First described in 1848, MM is part of...
Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients. Autologous stem cell transplantation (ASCT) improves survival in patients with previously untreated multiple myeloma (MM) and relapsed, chemotherapy-sensit... Mazumder,Kaufman,Nies...
The immunomodulatory drugs (IMiDs) lenalidomide and pomalidomide are highly effective treatments for multiple myeloma. However, virtually all patients eventually relapse due to acquired drug resistance with resistance-causing genetic alterations being fo